2/1/24 17:58 | 1/30/24 | VERA | Health | Drug | Pharmaceutical Preparations | Katabi Maha | CA | D | | P | 5,000 | 31.00 | 0 | 161 | 5 | 3,628 | I | | | | | | | | | | | | | | |
6/23/23 16:05 | 6/23/23 | VERA | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P | 83 | 16.60 | 0 | 5 | 9 | 60 | I | | | | | | | | | | | | | | |
6/22/23 16:10 | 6/20/23 | VERA | Health | Drug | Pharmaceutical Preparations | Commodore Capital LP | NY | T | | P | 6,799 | 15.17 | 0 | 448 | 9 | 5,450 | I | | | | | | | | | | | | | | |
4/3/23 16:05 | 3/30/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P | 17 | 7.24 | 0 | 2 | 0 | 1,949 | I | | | | | | | | | | | | | | |
3/30/23 16:07 | 3/28/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P | 173 | 7.24 | 0 | 24 | 1 | 1,947 | I | | | | | | | | | | | | | | |
3/28/23 16:05 | 3/24/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P.m | 25 | 7.24 | 0 | 3 | 0 | 1,923 | I | | | | | | | | | | | | | | |
3/21/23 16:40 | 3/17/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P.m | 637 | 7.13 | 0 | 89 | 5 | 1,920 | I | | | | | | | | | | | | | | |
3/17/23 16:10 | 3/15/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P.m | 660 | 7.10 | 0 | 93 | 5 | 1,830 | I | | | | | | | | | | | | | | |
3/14/23 16:05 | 3/10/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P | 343 | 7.16 | 0 | 48 | 3 | 1,737 | I | | | | | | | | | | | | | | |
3/7/23 16:07 | 3/3/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P | 7 | 7.25 | 0 | 1 | 0 | 1,689 | I | | | | | | | | | | | | | | |
3/3/23 16:07 | 3/1/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P.m | 170 | 7.24 | 0 | 23 | 1 | 1,688 | I | | | | | | | | | | | | | | |
2/27/23 16:07 | 2/23/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P | 1 | 7.24 | 0 | 0 | 0 | 1,665 | I | | | | | | | | | | | | | | |
2/17/23 16:19 | 2/6/23 | VERA | Health | Drug | Pharmaceutical Preparations | Young Joseph R | CA | O | SVP,Fina | P.a | 40 | 7.00 | 0 | 6 | 34 | 23 | D | | | | | | | | | | | | | | |
2/17/23 16:17 | 2/6/23 | VERA | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P.a | 100 | 7.00 | 0 | 14 | 40 | 50 | D | | | | | | | | | | | | | | |
2/15/23 18:32 | 2/13/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P | 72 | 7.20 | 0 | 10 | 1 | 1,665 | I | | | | | | | | | | | | | | |
2/13/23 16:04 | 2/9/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P | 3 | 7.25 | 0 | 0 | 0 | 1,655 | I | | | | | | | | | | | | | | |
2/9/23 16:36 | 2/3/23 | VERA | Health | Drug | Pharmaceutical Preparations | Seidenberg Beth C | CA | D | | P.m | 2,210 | 7.10 | 0 | 311 | 23 | 1,654 | I | | | | | | | | | | | | | | |
2/8/23 19:40 | 2/6/23 | VERA | Health | Drug | Pharmaceutical Preparations | Longitude Capital Partners Iv, LLC | CA | T | | P | 12,000 | 7.00 | 0 | 1,714 | 50 | 5,144 | I | | | | | | | | | | | | | | |
2/8/23 19:32 | 2/6/23 | VERA | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | CA | DT | | P | 12,000 | 7.00 | 0 | 1,714 | 50 | 5,144 | I | | | | | | | | | | | | | | |
2/8/23 18:29 | 2/6/23 | VERA | Health | Drug | Pharmaceutical Preparations | Sofinnova Venture Partners X, L.P. | CA | T | | P | 2,000 | 7.00 | 0 | 286 | 9 | 3,467 | D | | | | | | | | | | | | | | |
2/8/23 16:05 | 2/6/22 | VERA | Health | Drug | Pharmaceutical Preparations | Young Joseph R | CA | O | SVP,Fina | P | 40 | 7.00 | 0 | 6 | 34 | 23 | D | | | | | | | | | | | | | | |
2/8/23 16:04 | 2/6/22 | VERA | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P | 100 | 7.00 | 0 | 14 | 35 | 55 | D | | | | | | | | | | | | | | |
6/16/22 16:06 | 6/15/22 | VERA | Health | Drug | Pharmaceutical Preparations | Grant Sean | CA | O | CFO | P | 68 | 13.60 | 0 | 5 | 329 | 7 | I | | | | | | | | | | | | | | |